Single Stem Cell Dose Reverses Frailty in Older Adults

Imagine regaining the strength and endurance you thought aging had stolen forever, all from a single medical treatment. That's exactly what happened for older adults in a stunning new clinical trial testing stem cell therapy for frailty.

Researchers gave 148 adults aged 70 to 85 an infusion of laromestrocel, a therapy made from donated bone marrow stem cells. After nine months, those who received the highest dose walked an average of 60 meters further during a standard six-minute walk test compared to those who got a placebo. That's a 20% improvement in physical endurance.

Even more remarkable, one-third of the patients who received treatment saw their frailty scores drop so much they no longer qualified as frail. "Fully one-third of the people who got treated reverted to a two or a three on the scale, which are healthy scores," said Dr. Joshua Hare, chief science officer at Longeveron, the company developing the therapy.

Frailty affects 1 in 10 people over 65 and goes far beyond normal aging. It's a state of heightened vulnerability where infections, falls, or surgery can lead to rapid decline. Someone with severe frailty is five times more likely to die within a year than someone without it, according to the British Geriatric Society.

The difference between an 80-year-old in a nursing home and one still playing tennis comes down to biology, specifically inflammation. As we age, our immune systems become dysregulated, producing inflammatory molecules that damage blood vessels and accelerate muscle loss. Until now, doctors could only offer nutritional support and physical therapy.

The stem cells work differently. They're collected from donated bone marrow and given through an IV. Because they carry few surface proteins that trigger immune rejection, patients don't need risky immunosuppressive medications. The cells appear to calm inflammation and help the body repair itself.

The trial was randomized and placebo-controlled, meaning neither patients nor doctors knew who received the real treatment. Results tracked every three months showed a clear pattern: higher doses produced greater improvements. Meanwhile, the placebo group declined, as would be expected in untreated frail seniors.

The Bright Side

This represents the first real medical breakthrough for reversing frailty, not just slowing it down. "We've known for a long time that exercise can help, but that's often challenging, especially in the very frail," said Dr. Andrew Steele, director of The Longevity Initiative, who wasn't involved in the research. "So it's incredible to be able to not just slow the decline but show actual improvements with an infusion of stem cells."

The therapy also improved patient-reported outcomes like upper body strength and mobility. Researchers even identified a biological marker, soluble Tie2, that decreased in patients who received stem cells, providing evidence of reduced blood vessel inflammation.

Questions remain about exactly how the treatment works and how long the effects last, since the trial only followed participants for nine months. But for the first time, doctors have a tool that tackles frailty at its biological source, offering hope to millions of older adults who want to keep living full, independent lives.